Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11528 posts found.

CAR-T treatment is given ‘historic’ first approval by FDA

August 31, 2017 Research and Development, Sales and Marketing CAR-T, Kymriah, Novartis, biotech, drugs, pharma, pharmaceutical

Novartis has received approval for its CAR-T treatment of paediatric and young adults with a form of acute lymphoblastic leukaemia …
News

Abbott issues patch for vulnerable heart devices

August 31, 2017 Medical Communications, Sales and Marketing Abbot, St. Jude, biotech, drugs, pharma, pharmaceutical

A year on from the revelation that digital pacemakers were vulnerable to hackers, Abbott and the FDA has announced that …
News

EVP of Diabetes decamps from Sanofi to become Almirall CEO

August 30, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Almirall, Sanofi, biotech, drugs, pharma, pharmaceutical

Sanofi’s Executive Vice President of Diabetes & Cardiocascular, Peter Guenter, has opted to end his 22-year-long stay at the company …
Appointment

FDA approves first treatment for the ‘silent killer’

August 30, 2017 Research and Development, Sales and Marketing Chagas disease, FDA, biotech, drugs, pharma, pharmaceutical

The FDA has announced that it has granted an accelerated approval for the use of benznidazole in children between the ages …
News

FDA fast-tracks recreational drug MDMA for treatment of PTSD

August 30, 2017 Research and Development, Sales and Marketing FDA, MDMA, PTSD, life sciences, pharma, pharmaceuticals

In another leap forward for the promising treatment, the FDA has announced that it has granted Breakthrough Therapy Designation to …
News

The September 2017 issue of Pharmafocus is now live!

August 30, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Cancer Research UK, MSD, Pharmafocus, President trump, Takeda, Trump, charlottesville, life sciences, oncology, pharmaceuticals, phatma

The September edition of Pharmafocus is now available – click here to read online.
News

AstraZeneca unloads another drug for $400m

August 29, 2017 Research and Development, Sales and Marketing AstraZeneca, Takeda, biotech, drugs, pharma, pharmaceutical

AstraZeneca has had to do a serious re-think of its portfolio post-Mystic failure and it has made another move to …
News

Novartis names new Chief Digital Officer

August 29, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, appointment

Novartis has announced that it has appointed a new Chief Digital Officer in the form of Bertrand Bodson, who will …
Appointment

Thyroid disorders: An illness underestimated

August 29, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical

Dr Bogumila Urgatz, Medical Director, Department Global Medical Affairs & General Medicine and Endocrinology, Merck KGaA discusses thryoid problems and …
Feature

Gilead captures Kite in $11.9bn deal

August 29, 2017 Manufacturing and Production, Sales and Marketing Gilead, biotech, drugs, kite pharma, pharma, pharmaceutical

Gilead had long been expected to make a serious acquisition to boost flagging growth and it finally made a move …
News

Top Ten most popular articles on Pharmafile.com this week

August 25, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing life sciences, medicine, pharma, pharmaceutical, top ten

As much as it might try, the pharmaceutical industry just isn’t able to keep the drug pricing debate out of …
News

Seven years later, EC gives approval for Merck KGaA’s MS drug

August 25, 2017 Medical Communications, Sales and Marketing Mavenclad, Merck KGaA, biotech, drugs, multiple sclerosis, pharma, pharmaceutical

In 2011, Merck KGaA had all but given up on its MS drug after having been knocked back by both …
News

Samsung completes hat-trick of big biosimilar approvals

August 25, 2017 Medical Communications, Sales and Marketing Biogen, Samsung Bioepis, biosimilars, biotech, drugs, pharma, pharmaceutical

Samsung Bioepis has announced that it, alongside its partner Biogen, has secured European Commission approval for its biosimilar version of …
News

Roche receives FDA Priority Review for drug with potted history

August 24, 2017 Sales and Marketing Roche, biotech, drugs, emicizumab, pharma, pharmaceutical

Roche, alongside its subsidiary, Genentech, announced that it has received Priority Review for its haemophilia A drug, emicizumab, and that …
News

HIV home tests seized from market over potential risk

August 24, 2017 Sales and Marketing HIV, MHRA, biotech, drugs, pharma, pharmaceutical

The MHRA has removed over 100 HIV home testing kits from two UK based suppliers, after they were found not …
News
The Gateway to Local Adoption Series

Latest content

From lab breakthrough to NHS treatment: Getting innovative therapies to patients

September 5, 2026

Five Facts about NHS and primary care

September 5, 2026

Clinical trials don’t just have a recruitment problem, they have an enrolment protection problem.

September 5, 2026

AI in pharma: From lab development to patient impact

September 5, 2026

Back to basics: X-ray inspection in pharmaceutical and medical device production

September 5, 2026